Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Integral Diagnostics.
RELATED STOCKHEAD STORIES
Experts
Criterion’s small cap gems poised to star in 2025 (part one)
News
ASX Lunch Wrap: China-driven mining rally offset by tech slump on Nvidia probe
Health & Biotech
Broker Upgrades: Whole is greater than the sum, as Jarden urges buying into IDX-CAJ merger
Health & Biotech
ScoPo’s Powerplays: ASX health stocks rise as M&A activity heats up
Experts
MoneyTalks: Walk like an Egyptian, but Think like an Acquirer
Experts
SUNDAY ROAST: The stocks that lit a fire under our experts this week
Experts
MoneyTalks: The most irresistible ASX small cap takeover targets in 2024
Health & Biotech
ASX Health Stocks: Neuren up 17pc on DAYBUE sales, Argenica +40pc on Alzheimer’s data
News
10 at 11ish: MC Mining bounces on takeover bid, Block rockets
News
Market Highlights: Big rally on Wall Street, a soft landing scenario, and 5 ASX small caps to watch today
Experts
SUNDAY ROAST: The small caps that lit a fire under Stockhead’s experts this week
Experts
MoneyTalks: Why Goldman recommends these two ASX stocks in the booming diagnostic imaging space
News
ASX Escrow Watch: Rising star WA1 Resources among companies to release shares in November
Escrow Watch
Escrow Watch: Which companies have shares coming out in the new financial year?
News
Closing Bell: The stock formerly known as Hot Rock is up 70% and other great ASX Adventures
News
Trading Places: BGH ups Virtus stake to above 50pc as battle for fertility company escalates
Experts
